IL-5 but not interferon-gamma (IFN-gamma) inhibits eosinophil apoptosis by up-regulation of bcl-2 expression

被引:68
作者
Ochiai, K
Kagami, M
Matsumura, R
Tomioka, H
机构
[1] Department of Internal Medicine, Toho University School of Medicine, Sakura Hospital, Chiba
[2] Department of Internal Medicine, Toho University School of Medicine, Sakura Hospital, Sakura City, Chiha 285
关键词
eosinophil apoptosis; IL-5; IFN-gamma; bcl-2; antisense DNA;
D O I
10.1046/j.1365-2249.1997.d01-884.x
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
In order to determine regulatory mechanisms of eosinophil apoptosis. we examined the effect of recombinant IL-5 and interferon-gamma (IFN-gamma) on eosinophil apoptosis and bcl-2 expression. rhIL-5 (2.5 ng/ml) significantly inhibited eosinophil apoptosis in 96 h in vitro culture compared with medium only-cultured eosinophils (89.4 +/- 3.6% versus 31.3 +/- 12.2% (mean +/- s.d., n = 7, P < 0.05). Further, rhIL-5 significantly increased bcl-2 protein and mRNA expression on cultured eosinophils. A phosphorothioate antisense oligonucleotide targeted at the ATG translation initiation codon of bcl-2 (10(-5)M) could significantly block the supportive effect of rhIL-5 (0.25 ng/ml) for eosinophil survival compared with sense cDNA of bcl-2 on 96 h culture (inhibition rate 28.01 +/- 4.56% versus 0.07 +/- 1.73%; n = 4, P < 0.05). In contrast, rhIFN-gamma (100 U/ml) significantly inhibited eosinophil apoptosis on 96 h in vitro culture (72.7 +/- 10.5%; n = 7, P < 0.05), but did not significantly up-regulate bcl-2 protein and mRNA. These results indicate that IL-5 has inhibitory effects on eosinophil apoptosis by regulation of bcl-2 expression.
引用
收藏
页码:198 / 204
页数:7
相关论文
共 25 条
[1]  
BAKHSHI A, 1985, CELL, V41, P889
[2]   BCL-X, A BCL-2-RELATED GENE THAT FUNCTIONS AS A DOMINANT REGULATOR OF APOPTOTIC CELL-DEATH [J].
BOISE, LH ;
GONZALEZGARCIA, M ;
POSTEMA, CE ;
DING, LY ;
LINDSTEN, T ;
TURKA, LA ;
MAO, XH ;
NUNEZ, G ;
THOMPSON, CB .
CELL, 1993, 74 (04) :597-608
[3]  
BROIDE DH, 1990, J CLIN INVEST, V908, P1414
[5]   BCL-2 PROTOONCOGENE EXPRESSION IN NORMAL AND NEOPLASTIC HUMAN MYELOID CELLS [J].
DELIA, D ;
AIELLO, A ;
SOLIGO, D ;
FONTANELLA, E ;
MELANI, C ;
PEZZELLA, F ;
PIEROTTI, MA ;
DELLAPORTA, G .
BLOOD, 1992, 79 (05) :1291-1298
[6]   INTERLEUKIN-5 MESSENGER-RNA EXPRESSION BY EOSINOPHILS IN THE INTESTINAL-MUCOSA OF PATIENTS WITH CELIAC-DISEASE [J].
DESREUMAUX, P ;
JANIN, A ;
COLOMBEL, JF ;
PRIN, L ;
PLUMAS, J ;
EMILIE, D ;
TORPIER, G ;
CAPRON, A ;
CAPRON, M .
JOURNAL OF EXPERIMENTAL MEDICINE, 1992, 175 (01) :293-296
[7]   PURIFICATION OF HUMAN-BLOOD EOSINOPHILS BY NEGATIVE SELECTION USING IMMUNOMAGNETIC BEADS [J].
HANSEL, TT ;
POUND, JD ;
PILLING, D ;
KITAS, GD ;
SALMON, M ;
GENTLE, TA ;
LEE, SS ;
THOMPSON, RA .
JOURNAL OF IMMUNOLOGICAL METHODS, 1989, 122 (01) :97-103
[8]  
KAMESAKI H, 1994, J IMMUNOL, V152, P3294
[9]  
KELSO A, 1994, GROWTH FACTORS, V6, P233
[10]  
KOBAYASHI R, 1993, J IMMUNOL, V151, P7273